A combined intrapleural administration of dornase alfa and tissue plasminogen activator is safe in children with empyema - a pilot study.

Conclusions: The intrapleural treatment of dornase alfa and tissue plasminogen activator as treatment of empyema was safe in ten children with empyema. If confirmed in further studies, this combination of intrapleural therapy may improve the management of paediatric empyema. PMID: 31750793 [PubMed - as supplied by publisher]
Source: Acta Chirurgica Belgica - Category: Surgery Tags: Acta Chir Belg Source Type: research